Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.21% | 202.77 | 1.2% | $538.23m | |
| GILD | Gilead Sciences, Inc. | -0.90% | 75.62 | 0.9% | $479.42m | |
| BIIB | Biogen Inc. | -0.11% | 338.23 | 1.3% | $390.35m | |
| CELG | Celgene Corporation | 0.00% | 84.28 | 1.2% | $342.66m | |
| ILMN | Illumina, Inc. | 0.73% | 328.96 | 3.5% | $326.50m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.14% | 399.06 | 2.6% | $241.66m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.97% | 128.94 | 2.0% | $225.63m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.02% | 185.48 | 1.9% | $218.83m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.46% | 141.99 | 16.4% | $179.98m | |
| A | Agilent Technologies, Inc. | -0.37% | 67.21 | 1.5% | $160.39m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.06% | 106.07 | 4.4% | $146.21m | |
| LGND | Ligand Pharmaceuticals Incorporated | -3.73% | 203.01 | 23.3% | $122.43m | |
| VKTX | Viking Therapeutics, Inc. | -2.62% | 14.86 | 0.9% | $115.47m | |
| NKTR | Nektar Therapeutics | 0.24% | 50.59 | 5.6% | $107.97m | |
| EXAS | Exact Sciences Corporation | -2.06% | 66.05 | 25.3% | $105.10m |
Company Profile
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.